Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Ambrisentan (Myogen)George E BillmanFrontiers in Physiology|April 4, 2012
Effect of dietary omega-3 polyunsaturated Fatty acids on heart rate and heart rate variability in animals susceptible or resistant to ventricular fibrillationGeorge E BillmanCurrent Opinion in Investigational Drugs (London, England : 2000)|August 24, 2010
Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K(v)1.5 channels, for the potential treatment of atrial fibrillationGeorge E BillmanAmerican Journal of Physiology. Heart and Circulatory Physiology|February 28, 2006
Heart rate response to onset of exercise: evidence for enhanced cardiac sympathetic activity in animals susceptible to ventricular fibrillationGeorge E BillmanPharmacology & Therapeutics|August 19, 2008
The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapyGeorge E BillmanPharmacology & Therapeutics|February 18, 2006
A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug developmentGeorge E BillmanFrontiers in Physiology|August 30, 2013
The effect of heart rate on the heart rate variability response to autonomic interventionsGeorge E BillmanFrontiers in Physiology|March 27, 2020
Homeostasis: The Underappreciated and Far Too Often Ignored Central Organizing Principle of PhysiologyGeorge E BillmanPharmacology & Therapeutics|June 6, 2013
The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessmentGeorge E BillmanCurrent Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
RSD-1235. CardiomeGeorge E BillmanPageof 6